Publication details

Slizniční pemfigoid s očním postižením. Série případů

Title in English Mucous membrane pemphigoid wih ocular involvement. A case series
Authors

VOJTĚCHOVÁ Lucia JEDLIČKOVÁ Hana SLANINOVÁ Iva HAYEK Zuzana OLEJKOVÁ Tereza IVANIŠOVÁ Dominika MICHALCOVÁ Lenka HORÁČKOVÁ Monika

Year of publication 2024
Type Article in Periodical
Magazine / Source Česko-Slovenská Dermatologie
MU Faculty or unit

Faculty of Medicine

Citation
Keywords autoimmune bullous disease, mucous membrane pemphigoid, ocular pemphigoid, clinical characteristics, immunology, diagnosis, therapy
Description Mucous membrane pemphigoid is a rare autoimmune bullous disease with an annual incidence of 1 per million, typically starting at around 60 years of age. Clinical features include blisters and erosions with subsequent scarring, especially of the mucous membranes of the oral cavity, nose, eyes and genitals. Ocular pemphigoid is a severe type of mucous membrane pemphigoid affecting the conjunctiva. Due to the rarity of the disease, low sensitivity of standard investigations (histology and immunofluorescence investigation of tissue and serum) and unavailability of serological testing of laminin332 and ?6ß4 integrin (ELISA only for BP antigens), in many cases it is not possible to make an unequivocal diagnosis. Despite established therapy, we observe changes in disease activity and alternating periods of stabilization and progression. We describe a cohort of patients with mucous membrane pemphigoid with ocular involvement treated at our clinic in 2021–2022. We organized data on the current patient population with a focus on age, clinical features, investigations performed, disease course and management. The diagnosis was determined on the basis of clinical features, immunofluorescence and histological examination. Simultaneously, some patients' sera were tested foranti-laminin332 and anti-ß4integrin antibodies by western blot. We created this database with the aim of creating a comprehensive overview of patients with mucous pemphigoid and to ensure their consistent management at the dermatology and ophthalmology clinics.

You are running an old browser version. We recommend updating your browser to its latest version.

More info